Although prostate-specific antigen (PSA) is the main criteria for PCa diagnosis, it has poor specificity to cancer, highly expressed in noncancerous prostatic tissues as well as in cancerous tissues and often lead to over diagnosis and overtreatment. Here, KLK3 is linked to posterior cortical atrophy.